Gene therapy's high costs stem from several factors, including the intensive research and development required to create effective treatments, complex production processes, and the initial market exclusivity enjoyed by manufacturers. Additionally, the limited patient populations for many gene therapies contribute to higher prices. However, as research advances and production techniques improve, these costs are expected to decrease over time, making gene therapy more accessible to a broader range of patients.
Got more to add on this topic? Share your thoughts in the comments below!
Commentaires